Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Support us by your subscription

You have reached your monthly allowance of 1 free premium articles from The Pharmaceutical Journal and Clinical Pharmacist. Sign in or register for free to access 2 more articles. Subscribe for full access to The Pharmaceutical Journal and Clinical Pharmacist and CPD modules.

Note: CPD articles and modules are only available to full subscribers and members of the Royal Pharmaceutical Society. You can subscribe for as little as £5 a week.

Use the code0516EMSB2DP for 20% discount on our annual digital subscriptions.

Micrograph of multiple myeloma tumour cells (green) and bone cells (red) growing on a scaffold made of silk protein (purple), designed to resemble bone material

Multiple myeloma: pharmacological management

Although multiple myeloma is currently regarded as being incurable in the majority of patients, the outlook for patients diagnosed with the condition has improved markedly over the last 40 years, with survival rates quadrupling. Significant advances in both treatment and supportive therapies have contributed to these improved outcomes and are discussed in this article.

Are you already a registered user or a member of the Royal Pharmaceutical Society?

Sign in here

Institutional users can view premium content by verifying themselves with one of the following options:

myAthens Shibboleth

Subscribe to and support The Pharmaceutical Journal and Clinical Pharmacist

Subscribe today for as little as £5

Subscribe for as little as £5, to gain full, unlimited access to the ultimate source of information and news on pharmacy and pharmaceutical sciences.

Subscribe today

Register for free for more access

Alternatively, register for free to the site for access to an extra 2 premium articles for free.

Register now.

Need an institutional subscription?

Please contact The Pharmaceutical Journal directly, so we can provide you with detailed information about our institutional and corporate offerings.

Tel: +44 (0)20 7572 2221
Email: pjsubscription@rpharms.com

Or join the RPS for full access

Royal Pharmaceutical Society

As a pharmacist or pharmaceutical scientist, join the Royal Pharmaceutical Society and gain full access to pharmaceutical-journal.com

Membership is free for pharmacy students.

If your are not registered as a pharmacist in Great Britain or practise overseas, you may still be able to join the RPS as an associate member.

Become a member